👀 Ones to watch: Undervalued stocks to buy before they report Q3 earningsSee Undervalued Stocks

UBS raises Euronext stock target on valuation, CMD outlook

EditorAhmed Abdulazez Abdulkadir
Published 09/13/2024, 07:45 AM
ENX
-


On Friday, UBS updated its financial outlook for Euronext NV (ENX:FP) (OTC: EUXTF), raising the price target to €115.00 from €110.00, while reiterating a Buy rating on the stock. The adjustment comes ahead of Euronext's triennial Capital Markets Day (CMD) scheduled for November 8 in Paris. The firm highlighted that Euronext shares have seen a significant upswing this year, with a 27% increase year-to-date and a 9% rise since the H1:24 results were released in late July.


Despite the stock's strong performance, UBS pointed out that Euronext is still trading at a relatively low multiple from a historical perspective. Currently, the stock is trading at 14.9 times forward consensus earnings per share (EPS), which is below its average of 15.6 times from 2015 to the present. This valuation suggests that the stock may still be undervalued.


The anticipation of the upcoming CMD is seen as a potential positive event that could further stimulate investor interest in Euronext shares. UBS expects the market's reaction to this year's CMD to differ from the one that followed the 2021 CMD, where Euronext's shares dipped by 10% in the month after the event. At that time, the shares were trading at a higher multiple of 19.5 times forward EPS.


Furthermore, UBS noted that management at Euronext has established revenue and EBITDA growth targets for the years 2023-2027. These targets are set at 3-4% per annum for revenue and 5-6% per annum for EBITDA, which are slightly below the consensus expectations of 4.1% for revenue and 6.1% for EBITDA. This conservative guidance could potentially be a factor in the current valuation and future investor sentiment.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.